Australia: Avita Medical raises A$120m

Mike Perry, chief executive, Avita

Regenerative med-tech group Avita Medical has raised A$120m (US$82.1m) in an institutional placement to fund pipeline development of new indications. The company sold 203.4 million shares at A$0.59 per share – a 7.2% discount to the 30 day VWAP. “We are grateful for the confidence and conviction of the investors who have joined us in…

You must be a HMI Subscriber to view this content.

Subscribe Now »